metaEvidence - study list

meta|evidence oncology

Living systematic review and meta-analysis

metastatic/advanced - colorectal cancer (mCRC) 2
mCRC - (neo)adjuvant (NA)
mCRC - 1st line (L1) 5
mCRC - 2nd line (L2) 6
endometrial cancer 10

All treatments
chemotherapy
Standard of Care (SoC)
immune chekpoint inhibitors
anti-PD-(L)1
atezolizumab based treatment
atezolizumab plus FOLFOXIRI plus bevacizumab
durvalumab based treatment
nivolumab based treatment
nivolumab plus SoC
pembrolizumab based treatment
pembrolizumab alone

versus all
vs chemotherapy
vs Standard of Care (SoC)
vs VEGF(R) inhibitor
vs bevacizumab based treatment
vs Bevacizumab plus FOLFOXIRI

study list
mapping
overview
meta-analysis
forest plot
NMA
excluded


	Study	study type RCT OBS RCT + OBS	Pathology	T1	T0	Patients	sample sizes	ROB	Results

delta: difference in rate or median (if available)

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -

Extraction panel open

An extraction panel is open